Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy
作者： Kyung S. Lee , Terrence R. Burke , Jung-Eun Park , Jeong K. Bang , Eunhye Lee
DOI: 10.1016/J.TIPS.2015.08.013
关键词:
摘要: Polo-like kinase 1 (Plk1) plays key roles in regulating mitotic processes that are crucial for cellular proliferation. Overexpression of Plk1 is tightly associated with the development of …
elsevier.com
sci-hub.se 参考文章(153)
Manabu Takagi, Takuya Honmura, Shuuji Watanabe, Reiko Yamaguchi, Masaki Nogawa, Ikumi Nishimura, Fumitaka Katoh, Masato Matsuda, Hiroyoshi Hidaka, In vivo antitumor activity of a novel sulfonamide, HMN-214, against human tumor xenografts in mice and the spectrum of cytotoxicity of its active metabolite, HMN-176. Investigational New Drugs. ,vol. 21, pp. 387- 399 ,(2003) , 10.1023/A:1026282716250
Irena Melnikova, James Golden, Targeting protein kinases Nature Reviews Drug Discovery. ,vol. 3, pp. 993- 994 ,(2004) , 10.1038/NRD1600
Walter M. Stadler, David J. Vaughn, Guru Sonpavde, Nicholas J. Vogelzang, Scott T. Tagawa, Daniel P. Petrylak, Peter Rosen, Chia-Chi Lin, John Mahoney, Sanjiv Modi, Peter Lee, Marc S. Ernstoff, Wu-Chou Su, Alexander Spira, Korinna Pilz, Richard Vinisko, Charles Schloss, Holger Fritsch, Charles Zhao, Michael A. Carducci, An open‐label, single‐arm, phase 2 trial of the polo‐like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer Cancer. ,vol. 120, pp. 976- 982 ,(2014) , 10.1002/CNCR.28519
K S Lee, R L Erikson, Plk is a functional homolog of Saccharomyces cerevisiae Cdc5, and elevated Plk activity induces multiple septation structures. Molecular and Cellular Biology. ,vol. 17, pp. 3408- 3417 ,(1997) , 10.1128/MCB.17.6.3408
Michael Kothe, Darcy Kohls, Simon Low, Rocco Coli, Glen R. Rennie, Frederic Feru, Cyrille Kuhn, Yuan-Hua Ding, Selectivity-determining residues in Plk1. Chemical Biology & Drug Design. ,vol. 70, pp. 540- 546 ,(2007) , 10.1111/J.1747-0285.2007.00594.X
Ju Hee Kim, Bonsu Ku, Kyung S. Lee, Seung Jun Kim, Structural analysis of the polo‐box domain of human Polo‐like kinase 2 Proteins. ,vol. 83, pp. 1201- 1208 ,(2015) , 10.1002/PROT.24804
Wen-Jian Qian, Jung-Eun Park, Robert Grant, Christopher C. Lai, James A. Kelley, Michael B. Yaffe, Kyung S. Lee, Terrence R. Burke, Neighbor-directed histidine N (τ)-alkylation: A route to imidazolium-containing phosphopeptide macrocycles Biopolymers. ,vol. 104, pp. 663- 673 ,(2015) , 10.1002/BIP.22698
Eric F. Johnson, Kent D. Stewart, Keith W. Woods, Vincent L. Giranda, Yan Luo, Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity. Biochemistry. ,vol. 46, pp. 9551- 9563 ,(2007) , 10.1021/BI7008745
Wei Dai, Yaqin Li, Bin Ouyang, Huiqi Pan, Peter Reissmann, Jian Li, Jonathan Wiest, Peter Stambrook, Jack L. Gluckman, Amy Noffsinger, Pablo Bejarano, PRK, a cell cycle gene localized to 8p21, is downregulated in head and neck cancer. Genes, Chromosomes and Cancer. ,vol. 27, pp. 332- 336 ,(2000) , 10.1002/(SICI)1098-2264(200003)27:3<332::AID-GCC15>3.0.CO;2-K
Philip Cohen, Dario R. Alessi, Kinase Drug Discovery – What’s Next in the Field? ACS Chemical Biology. ,vol. 8, pp. 96- 104 ,(2013) , 10.1021/CB300610S